ES2035317T5 - Metodo para analizar celulas hematopoyeticas en una muestra. - Google Patents

Metodo para analizar celulas hematopoyeticas en una muestra.

Info

Publication number
ES2035317T5
ES2035317T5 ES88310507T ES88310507T ES2035317T5 ES 2035317 T5 ES2035317 T5 ES 2035317T5 ES 88310507 T ES88310507 T ES 88310507T ES 88310507 T ES88310507 T ES 88310507T ES 2035317 T5 ES2035317 T5 ES 2035317T5
Authority
ES
Spain
Prior art keywords
sample
analyzing
cells
hematopoyetic
hematopoyetic cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88310507T
Other languages
English (en)
Other versions
ES2035317T3 (es
Inventor
Michael R Loken
Virendra O Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22378975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2035317(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Publication of ES2035317T3 publication Critical patent/ES2035317T3/es
Application granted granted Critical
Publication of ES2035317T5 publication Critical patent/ES2035317T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N15/1456Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals
    • G01N15/1459Optical investigation techniques, e.g. flow cytometry without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals the analysis being performed on a sample stream
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N2015/1006Investigating individual particles for cytology
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1402Data analysis by thresholding or gating operations performed on the acquired signals or stored data
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10Investigating individual particles
    • G01N15/14Optical investigation techniques, e.g. flow cytometry
    • G01N2015/1477Multiparameters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

UN METODO Y CONJUNTO PARA LA IDENTIFICACION DE ORIGENES Y ETAPAS DE CELULAS HEMATOPOYETICAS EN UNA MUESTRA, DONDE LAS CELULAS SE TRATAN CON ANTICUERPOS MONOCLONALES MARCADOS ELEGIDOS PARA DISTINGUIR ENTRE CADA ORIGEN Y ETAPAS DE MADURACION DENTRO DE CADA ORIGEN.
ES88310507T 1987-11-09 1988-11-08 Metodo para analizar celulas hematopoyeticas en una muestra. Expired - Lifetime ES2035317T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11849887A 1987-11-09 1987-11-09

Publications (2)

Publication Number Publication Date
ES2035317T3 ES2035317T3 (es) 1993-04-16
ES2035317T5 true ES2035317T5 (es) 1998-03-16

Family

ID=22378975

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88310507T Expired - Lifetime ES2035317T5 (es) 1987-11-09 1988-11-08 Metodo para analizar celulas hematopoyeticas en una muestra.

Country Status (7)

Country Link
US (1) US5137809A (es)
EP (1) EP0317156B2 (es)
JP (1) JPH06105253B2 (es)
AT (1) ATE81724T1 (es)
DE (1) DE3875456T3 (es)
ES (1) ES2035317T5 (es)
GR (2) GR3006183T3 (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013974A1 (en) * 1990-03-14 1991-09-19 The Biomembrane Institute Monoclonal antibody and immunoconjugates for the treatment and detection of b cell disorders
US5622853A (en) * 1990-05-01 1997-04-22 Becton Dickinson And Company T lymphocyte precursor
US5185438A (en) * 1991-04-02 1993-02-09 The Trustees Of Princeton University Nucleic acids encoding hencatoporetic stem cell receptor flk-2
US5367057A (en) 1991-04-02 1994-11-22 The Trustees Of Princeton University Tyrosine kinase receptor flk-2 and fragments thereof
GR920100123A (el) * 1991-04-12 1993-03-16 Ortho Diagnostic Systems Inc Αντιδραστήριο πολυχρωματικής κηλίδωσης και μέ?οδος ανάλυσης.
FR2676847A1 (fr) * 1991-05-22 1992-11-27 Immunotech Sa Procede d'enumeration des reticulocytes et les kits destines a cette enumeration.
FR2684186B1 (fr) * 1991-11-25 1994-02-25 Pasteur Sanofi Diagnostics Trousse pour le denombrement rapide des granulocytes, et procede utilisant ladite trousse.
ES2051651B1 (es) * 1992-12-10 1995-01-01 Univ Salamanca Procedimiento para la cuantificacion simultanea, en una sola medicion, de los principales tipos de linfocitos humanos y sus subpoblaciones.
US5692220A (en) * 1993-09-02 1997-11-25 Coulter Corporation Decision support system and method for diagnosis consultation in laboratory hematopathology
EP0685071A4 (en) * 1993-11-12 2000-12-13 Becton Dickinson Co METHOD FOR ABSOLUTE COUNTING OF RARE CELLS
FI951778L (fi) * 1995-04-12 1996-10-13 Aboatech Ab Oy Menetelmä allergian toteamiseksi
US5876956A (en) * 1995-05-15 1999-03-02 Johns Hopkins University School Of Medicine Methods for identification or purification of cells containing an enzymatic intracellular marker
US6117985A (en) 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6306575B1 (en) 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
DE69626418T2 (de) * 1995-11-13 2003-11-13 Biotransplant, Inc. Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation
WO1998009647A2 (en) * 1996-09-06 1998-03-12 Medarex, Inc. Cyanidin compositions and therapeutic and diagnostic uses therefor
JP3620946B2 (ja) 1997-03-17 2005-02-16 シスメックス株式会社 スキャッタグラムの表示方法および粒子計測装置
AU3712200A (en) * 1999-03-01 2000-09-21 Board Of Trustees Of The Leland Stanford Junior University Rapid assay for chorioamnionitis
AU3862200A (en) * 1999-03-01 2000-09-21 Board Of Trustees Of The Leland Stanford Junior University Rapid assay for infection in small children
CA2366514C (en) * 1999-04-13 2009-09-15 Manfred Schmitt Diagnostic and therapeutic use of antibodies against the urokinase receptor
US6900023B1 (en) 1999-09-02 2005-05-31 Sysmex Corporation Method for classifying and counting leukocytes
US7300763B2 (en) 2000-06-08 2007-11-27 Teijin Limited Method of testing myelotoxicity with the use of flow cytometer
US7393656B2 (en) * 2001-07-10 2008-07-01 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for risk stratification
US7381535B2 (en) * 2002-07-10 2008-06-03 The Board Of Trustees Of The Leland Stanford Junior Methods and compositions for detecting receptor-ligand interactions in single cells
US7695926B2 (en) 2001-07-10 2010-04-13 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting receptor-ligand interactions in single cells
AU2002365421A1 (en) 2001-07-10 2003-09-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for detecting the activation state of the multiple proteins in single cells
PT1363126E (pt) * 2002-05-14 2006-05-31 Univ Salamanca Analise multidimensional diferencial de leucocitos
PT1458853E (pt) * 2002-05-16 2010-02-23 Absorber Ab Processos de prova directa de compatibilidade específicos para dadores
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
NZ537277A (en) * 2002-07-18 2008-04-30 Crucell Holland Bv Recombinant production of mixtures of antibodies
US7507548B2 (en) 2003-03-04 2009-03-24 University Of Salamanca Multidimensional detection of aberrant phenotypes in neoplastic cells to be used to monitor minimal disease levels using flow cytometry measurements
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
ES2408582T3 (es) * 2003-05-30 2013-06-21 Merus B.V. Biblioteca de Fab para la preparación de una mezcla de anticuerpos
DK1737971T3 (da) 2004-01-20 2017-11-13 Merus Nv Blandinger af bindingsproteiner
WO2005085845A1 (es) * 2004-03-03 2005-09-15 Universidad De Salamanca Deteccion multidimensional de fenotipos aberrantes en celulas neoplasicas para monitorizar niveles minimos de enfermedad utilizando citometria de flujo
ATE481477T1 (de) * 2004-03-09 2010-10-15 Absorber Ab Endothelvorläuferzellen und verfahren zur verwendung davon
US7625712B2 (en) 2004-05-21 2009-12-01 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
US7674598B2 (en) 2004-05-21 2010-03-09 Beckman Coulter, Inc. Method for a fully automated monoclonal antibody-based extended differential
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
CN105168250B (zh) 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
US7972596B2 (en) 2004-11-18 2011-07-05 Imclone Llc Antibodies against vascular endothelial growth factor receptor-1
JP2008528975A (ja) * 2005-01-24 2008-07-31 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ 細胞シグナル伝達系のモデリングのためのベイジアンネットワークの使用
US7321843B2 (en) * 2005-09-30 2008-01-22 Universidad De Salamanca Method for generating new flow cytometry data files containing an infinite number of dimensions based on data estimation
AU2005234696B2 (en) 2005-11-18 2012-02-16 Phanos Technologies, Inc. Fluorescent membrane intercalating probes and methods for their use
US8383095B2 (en) * 2006-02-14 2013-02-26 Cellerant Therapeutics, Inc. Methods and compositions for enhancing engraftment of hematopoietic stem cells
US7816135B2 (en) 2007-07-05 2010-10-19 Becton, Dickinson And Company Method of analyzing lymphocytes
JP2011502264A (ja) 2007-10-29 2011-01-20 ベックマン コールター, インコーポレイテッド 血小板集団の迅速な抗体ベースの分析のための方法
BRPI0910622A2 (pt) 2008-04-25 2020-03-10 Dyax Corp. ANTICORPOS CONTRA FcRn E USOS DOS MESMOS
WO2009134944A2 (en) * 2008-04-29 2009-11-05 Nodality, Inc. Methods of determining the health status of an individual
US20090291458A1 (en) * 2008-05-22 2009-11-26 Nodality, Inc. Method for Determining the Status of an Individual
EP2304436A1 (en) 2008-07-10 2011-04-06 Nodality, Inc. Methods for diagnosis, prognosis and treatment
US8399206B2 (en) 2008-07-10 2013-03-19 Nodality, Inc. Methods for diagnosis, prognosis and methods of treatment
US20110262446A1 (en) 2008-10-14 2011-10-27 Dyax Corp. Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
US20100099109A1 (en) * 2008-10-17 2010-04-22 Nodality, Inc., A Delaware Corporation Methods for Analyzing Drug Response
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
EP3459564B1 (en) 2010-01-06 2021-10-27 Takeda Pharmaceutical Company Limited Plasma kallikrein binding proteins
EP2601212A1 (en) 2010-08-04 2013-06-12 Cizzle Biotechnology Limited Methods and compounds for the diagnosis and treatment of
CN103492016A (zh) 2010-11-23 2014-01-01 普莱萨格生命科学公司 用于实体递送的治疗方法和组合物
KR102014554B1 (ko) 2011-06-02 2019-08-26 다이액스 코포레이션 Fc 수용체 결합 단백질
SI2838917T1 (sl) 2012-04-20 2019-11-29 Merus Nv Postopki in sredstva za produkcijo heterodimernih IG-podobnih molekul
ES2869701T3 (es) 2012-08-01 2021-10-25 United Therapeutics Corp Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
CA2880808C (en) 2012-08-01 2023-01-24 United Therapeutics Corporation Treatment of pulmonary arterial hypertension with mesenchymal stem cells
JP6431850B2 (ja) 2013-01-09 2018-11-28 ユナイテッド セラピューティクス コーポレイション プロスタサイクリンおよび間葉系幹細胞による脈管障害の処置
DK3060653T3 (da) 2013-10-24 2019-06-11 Neuroplast Beheer B V Fremgangsmåde til reduktion af den inflammatoriske aktivitet i et stamcelletransplantat og anvendelse deraf
EP4202036A1 (en) 2015-07-20 2023-06-28 Angiocrine Bioscience, Inc. Methods and compositions for stem cell transplantation
US11207393B2 (en) 2015-10-16 2021-12-28 President And Fellows Of Harvard College Regulatory T cell PD-1 modulation for regulating T cell effector immune responses
JP2019512271A (ja) 2016-03-21 2019-05-16 デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド T細胞疲弊状態特異的遺伝子発現調節因子およびその使用
US10202641B2 (en) 2016-05-31 2019-02-12 Cellular Research, Inc. Error correction in amplification of samples
ES2927406T3 (es) 2016-10-24 2022-11-04 United Therapeutics Corp Potenciación de las propiedades inmunomoduladoras de las MSC mediante treprostinil
JP7536450B2 (ja) 2017-06-05 2024-08-20 ベクトン・ディキンソン・アンド・カンパニー 単一細胞用のサンプルインデックス付加
US12227548B2 (en) 2018-11-19 2025-02-18 Dana-Farber Cancer Institute, Inc. Use of IRE1α-XBP1 signaling pathway biomarkers for modulating immune responses
CN113454234B (zh) 2019-02-14 2025-03-18 贝克顿迪金森公司 杂合体靶向和全转录物组扩增
EP4090764A1 (en) 2020-01-13 2022-11-23 Becton, Dickinson and Company Cell capture using du-containing oligonucleotides
WO2021155057A1 (en) 2020-01-29 2021-08-05 Becton, Dickinson And Company Barcoded wells for spatial mapping of single cells through sequencing
EP4111168A1 (en) * 2020-02-25 2023-01-04 Becton Dickinson and Company Bi-specific probes to enable the use of single-cell samples as single color compensation control
EP4150118A1 (en) 2020-05-14 2023-03-22 Becton Dickinson and Company Primers for immune repertoire profiling
US12157913B2 (en) 2020-06-02 2024-12-03 Becton, Dickinson And Company Oligonucleotides and beads for 5 prime gene expression assay
US11932901B2 (en) 2020-07-13 2024-03-19 Becton, Dickinson And Company Target enrichment using nucleic acid probes for scRNAseq
WO2022026909A1 (en) 2020-07-31 2022-02-03 Becton, Dickinson And Company Single cell assay for transposase-accessible chromatin
EP4263859A1 (en) 2020-12-15 2023-10-25 Becton, Dickinson and Company Single cell secretome analysis
US20250319183A1 (en) 2021-04-07 2025-10-16 David Avigan Compositions and methods for the treatment of cancer
WO2023086969A2 (en) 2021-11-12 2023-05-19 Ichor Medical Systems Inc. Treatment methods

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107413A (en) * 1977-03-02 1978-09-19 Nippon Baiotesuto Kenkiyuushiy Detecting method and reagent kit for antibody against leucocyte
GB2057685B (en) * 1979-03-19 1983-12-21 Int Diagnostic Tech Double tagged immunoassay
JPS5745454A (en) * 1980-09-02 1982-03-15 Fuji Photo Film Co Ltd Immunochemical measuring method for various minor components
JPS58171671A (ja) * 1982-04-01 1983-10-08 Fujitsu Ltd 細胞分類方法
US4607007A (en) * 1983-04-07 1986-08-19 Becton, Dickinson And Company Differentiation of natural killer cell subpopulations of cells
US4581334A (en) * 1983-04-25 1986-04-08 Ortho Diagnostics Systems, Inc. Simultaneous detection of leukocyte phagocytic and killing ability
US4599307A (en) * 1983-07-18 1986-07-08 Becton, Dickinson And Company Method for elimination of selected cell populations in analytic cytology
US4645738A (en) * 1983-09-30 1987-02-24 Memorial Sloan-Kettering Institute Cancer Center Method for differential diagnosis of T cell leukemias using monoclonal antibodies
US4599304A (en) * 1983-10-07 1986-07-08 Becton, Dickinson And Company Method for monitoring activated cell subpopulations
US4654312A (en) * 1984-05-14 1987-03-31 Becton, Dickinson And Company Lysing agent for analysis of peripheral blood cells
JPH0652409B2 (ja) * 1984-08-08 1994-07-06 富士写真フイルム株式会社 ハロゲン化銀カラー写真感光材料
US4677061A (en) * 1984-10-19 1987-06-30 Genetic Systems Corporation T-cell lymphocyte subset monitoring of immunologic disease
US4727020A (en) * 1985-02-25 1988-02-23 Becton, Dickinson And Company Method for analysis of subpopulations of blood cells
CA1279008C (en) * 1985-10-11 1991-01-15 Smith Kline & French Canada Ltd. Methods and reagents for performing subset analysis
DE3541033A1 (de) * 1985-11-19 1987-05-21 Boehringer Mannheim Gmbh Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz

Also Published As

Publication number Publication date
DE3875456D1 (de) 1992-11-26
US5137809A (en) 1992-08-11
JPH01161153A (ja) 1989-06-23
JPH06105253B2 (ja) 1994-12-21
EP0317156B1 (en) 1992-10-21
ATE81724T1 (de) 1992-11-15
ES2035317T3 (es) 1993-04-16
EP0317156A1 (en) 1989-05-24
GR3025901T3 (en) 1998-04-30
DE3875456T2 (de) 1993-03-04
GR3006183T3 (en) 1993-06-21
EP0317156B2 (en) 1997-11-12
DE3875456T3 (de) 1998-06-10

Similar Documents

Publication Publication Date Title
ES2035317T5 (es) Metodo para analizar celulas hematopoyeticas en una muestra.
GB2055851A (en) Method and kit for enzyme immunoassay of biological substances
ES526991A0 (es) Un metodo para evaluar la probabilidad de malignidad celular en una muestra biologica de un haspedante humano.
DE3481775D1 (de) Verfahren zum raschen nachweis von mikroorganismen in klinischen proben.
DE3173597D1 (en) Specific antibody and its use in an enzyme immuno assay
NO164252C (no) Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter.
BR8108803A (pt) Processo e aparelho para determinacao quantitativa do nivel de hemoglobina em uma amostra biologica
ES2059478T3 (es) Co-expresion en celulas eucarioticas.
FI884472L (fi) Määrityskitti ja -menetelmä kokonaisten solujen immunologiseen määritykseen
DE2965570D1 (en) Method for the detection and/or determination of an antigen specific immunoglobulin, immuno-reagents to be used in said method and test kit for said determination
JPS5526899A (en) Measuring of amino group transfering enzyme in biological fluid and combination reagent used therein
DE3884731D1 (de) Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin.
DE3765147D1 (de) Verfahren und reagenz zur bestimmung von gesamt-bilirubin.
BR8107322A (pt) Processo de analise de organismos presentes no meio rural
DE3585049D1 (de) Monoklonale antikoerper.
IT1141587B (it) Laboratorio prefabbricato e analizzatore di ottano
ES539223A0 (es) Mejoras intruducidas en un ensayo para determinar un antigeno bacteriano en una muestra de ensayo
IT1114891B (it) Metodo e corredo di prova per la determinazione di amilasi nel siero
NZ227184A (en) Method, slide and kit for assaying collagenolytic activity of mammalian biological fluids involving the use of collagen
JPS576364A (en) Immunologic inspection of oncofetal antigent and diagnostic method and kit utilizing thereof
SE468853B (sv) Nytt lymfokin, monoklonala antikroppar specifika foer lymfokinet och deras framstaellning samt anvaendningar
EP0266686A3 (en) Latex agglutination method for the detection of an antibody against streptococcus deoxyribonuclease b
EP0179868A4 (en) ORGANIC REAGENTS MARKED BY CHEMOLUMINESCENCE AND THEIR USE IN THE ANALYSIS OF ORGANIC COMPOUNDS.
BR8502804A (pt) Corantes reativos,processo para sua obtencao e utilizacao
DE3767659D1 (de) Verfahren und testelement zum auffinden von zellaesionen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 317156

Country of ref document: ES